Stacey Limauro, Executive Director of Clinical Operations at Deciphera Pharmaceuticals has over 25 years of industry experience across all Phases of clinical development in both small and large Pharma organizations. In her current role, she provides leadership and oversight for the entire clinical development operations team and portfolio at Deciphera, including contributing to the operational strategy and implementation of process development and improvement within the department. One of Stacey’s most influential accomplishments was leading the successful approval of Deciphera’s first drug, QUINLOCK in 2020 for the treatment of GIST. She enjoys working with high performing cross-functional teams to bring therapeutic treatments to patients in need. She received her BS in Chemistry from Trinity College in CT, and an MS in Biochemistry from Boston College in MA.
